Featured Research

from universities, journals, and other organizations

New Experiments Show Genes Play Significant Role In Fear

Date:
October 29, 1997
Source:
University Of Colorado At Boulder
Summary:
A group of faculty, graduate and undergraduate students at the University of Colorado at Boulder have found new evidence that genes play a key role in individual differences regarding fear-related learning in a study of two genetic strains of mice.

A group of faculty, graduate and undergraduate students at the University of Colorado at Boulder have found new evidence that genes play a key role in individual differences regarding fear-related learning in a study of two genetic strains of mice.

Twin studies in humans have provided evidence for a "substantial genetic component" underlying differences in susceptibility to extreme reactions to fear-inducing events, said Jeanne Wehner, a professor at CU-Boulder's Institute for Behavioral Genetics. "Our primary interest is individual differences in learning and memory," she said. "Animal models allow us to map the genes much more quickly and easily."

In a series of experiments, the CU researchers exposed two strains of mice to light electroshocks in conjunction with an audible clicking sound. Since the primary fear reaction of mice is to freeze, each rodents' freezing behavior was charted when the animals were later subjected to the clicking sound alone, to the environment in which the sound and shock were administered together, and in an altered physical environment, Wehner said.

The researchers identified the genetic links by analyzing genetic similarities and differences between mice exhibiting extreme fear conditioning with mice exhibiting significantly less fear. The strongest link was on a portion of chromosome 1, which may contain hundreds of genes, she said. There also were weaker links to chromosomes 10 and 16.

The genetic research has implications for human disorders like post-traumatic stress, assuming researchers can pinpoint analogous genes for fear conditioning in humans, she said. New pharmacological agents developed specifically to target human genes implicated in fear-related disorders could be used in treating a variety of human emotional problems.

A paper on the subject by CU-Boulder's Wehner, Richard Radcliffe, Shelby Rosman, Steven Christiansen, Duffy Rassmussen, David Fulker and Michelle Wiles appears in the November 1997 issue of Nature Genetics.

The group used 84 DNA markers, unique chemical road signs on each chromosome that allow researchers to track associated genes. CU researchers have begun sequencing the genes in a search for likely candidates.

A companion paper in the November issue of Nature Genetics by a group from the State Department of Health in Albany, N.Y., also concluded chromosome 1 was significantly involved in fear conditioning in mice.

The same region of chromosome 1 was implicated in a 1995 study by Oxford University's Jonathan Flint and CU-Boulder's John DeFries, David Fulker and Allan Collins. The study focused on emotionality in mice following a series of experiments that exposed mice to brightly lit open areas.

In addition, a 1997 study by an international research team led by Howard Gershenfeld of the University of Texas Southwestern Medical Center in Dallas showed similar results. "There are now four separate studies on fear responses in animals that implicate this portion of chromosome 1," said Wehner, whose research is funded by NIH. "The thing we need to do now is get at the gene or genes involved."

In 1992, Wehner was part of a national team that identified a gene associated with spatial learning in mice. "We are very interested in complex learning behavior," she said. "In this case we chose the fear-conditioning component for testing as a way to try and understand individual genetic differences in learning."


Story Source:

The above story is based on materials provided by University Of Colorado At Boulder. Note: Materials may be edited for content and length.


Cite This Page:

University Of Colorado At Boulder. "New Experiments Show Genes Play Significant Role In Fear." ScienceDaily. ScienceDaily, 29 October 1997. <www.sciencedaily.com/releases/1997/10/971029055733.htm>.
University Of Colorado At Boulder. (1997, October 29). New Experiments Show Genes Play Significant Role In Fear. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1997/10/971029055733.htm
University Of Colorado At Boulder. "New Experiments Show Genes Play Significant Role In Fear." ScienceDaily. www.sciencedaily.com/releases/1997/10/971029055733.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins